Henry Patton Doggrell Insider Profile
4 Followers
Henry Patton Doggrell, former VP, Chief Legal Officer at Oncternal Therapeutics, holds 48.17K shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Henry Patton Doggrell Sold 7,351 shares of Oncternal Therapeutics on Jun 22, 2018 for an estimated value of $139.67K.
Henry Patton Doggrell's Trading History
You May Also Like
Henry Patton Doggrell insider profile FAQ
What is the percentage of profitable transactions made by Henry Patton Doggrell?
The percentage of profitable transactions made by Henry Patton Doggrell is 50%.
What is the average return per transaction made by Henry Patton Doggrell?
The average return per transaction made by Henry Patton Doggrell is 39.50%.
What stocks does Henry Patton Doggrell hold?
Henry Patton Doggrell holds: ONCT stocks.
What was Henry Patton Doggrell’s latest transaction?
Henry Patton Doggrell’s latest transaction was an Informative Sell of $139.67K.
What was Henry Patton Doggrell's most profitable transaction?
Henry Patton Doggrell’s most profitable transaction was an Informative Sell of ONCT stock on June 22, 2018. The return on the trade was 94.30%.
What is Henry Patton Doggrell's role in Oncternal Therapeutics?
Henry Patton Doggrell's role in Oncternal Therapeutics is VP, Chief Legal Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
